D-0070-2021 Class II Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0070-2021 was initiated by AVKARE Inc. on Oct 30, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 15,678 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 18, 2020
Initiation Date
Oct 30, 2020
Termination Date
Jun 2, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,678 bottles

Product description

Mesalamine Delayed-Release Tablets, USP 1.2 gram (Once-Daily), 120 Tablets bottle, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478 NDC 42291-564-12

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lots: 26085 Exp. 07/2021, 26426 Exp. 01/2022, 26983 Exp. 04/2022, 28647 Exp. 06/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0070-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0070-2021. Report a data issue: hello@regdatalab.com.